LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 84.45 | 84.90 | 9769 | 8254 | 1.1834 | 1.0517 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 86.16 | 84.90 | 122 | 8141 | 0.0150 | 0.0566 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 86.16 | 84.90 | 9626 | 8141 | 1.1823 | 1.0515 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 86.16 | 84.90 | 6426 | 8141 | 0.7893 | 0.9294 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 86.16 | 84.90 | 9780 | 8141 | 1.2012 | 1.0565 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.86 | 84.90 | 135 | 7680 | 0.0176 | 0.0740 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.86 | 84.90 | 9811 | 7680 | 1.2774 | 1.0768 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.86 | 84.90 | 5118 | 7680 | 0.6664 | 0.8789 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.86 | 84.90 | 9807 | 7680 | 1.2769 | 1.0766 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 89.57 | 84.90 | 151 | 7494 | 0.0201 | 0.0932 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 89.57 | 84.90 | 10062 | 7494 | 1.3426 | 1.0933 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 89.57 | 84.90 | 3755 | 7494 | 0.5010 | 0.7972 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 89.57 | 84.90 | 9781 | 7494 | 1.3051 | 1.0841 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 91.27 | 84.90 | 143 | 7420 | 0.0193 | 0.0842 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 91.27 | 84.90 | 10264 | 7420 | 1.3833 | 1.1032 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 91.27 | 84.90 | 2149 | 7420 | 0.2896 | 0.6504 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 91.27 | 84.90 | 9780 | 7420 | 1.3180 | 1.0875 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 92.98 | 84.90 | 149 | 7257 | 0.0205 | 0.0916 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 92.98 | 84.90 | 10491 | 7257 | 1.4455 | 1.1182 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 92.98 | 84.90 | 1216 | 7257 | 0.1676 | 0.5140 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 92.98 | 84.90 | 9770 | 7257 | 1.3462 | 1.0948 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 94.68 | 84.90 | 70 | 7000 | 0.0100 | -0.0299 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 94.68 | 84.90 | 10701 | 7000 | 1.5286 | 1.1379 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 94.68 | 84.90 | 444 | 7000 | 0.0634 | 0.2968 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 94.68 | 84.90 | 9759 | 7000 | 1.3941 | 1.1072 | MN20160318_Q02 | I04 |